156 related articles for article (PubMed ID: 7811027)
1. In vitro activities of metronidazole and its hydroxy metabolite against Bacteroides spp.
Pendland SL; Piscitelli SC; Schreckenberger PC; Danziger LH
Antimicrob Agents Chemother; 1994 Sep; 38(9):2106-10. PubMed ID: 7811027
[TBL] [Abstract][Full Text] [Related]
2. In vitro activity of azlocillin, metronidazole and its hydroxy metabolite against anaerobes. Bacteriostatic synergism studies.
Werner H; Schädler G; Krasemann C
Arzneimittelforschung; 1983; 33(4):574-7. PubMed ID: 6683537
[TBL] [Abstract][Full Text] [Related]
3. Relative susceptibilities of Gardnerella vaginalis (Haemophilus vaginalis), Neisseria gonorrhoeae, and Bacteroides fragilis to Metronidazole and its two major metabolites.
Ralph ED; Amatnieks YE
Sex Transm Dis; 1980; 7(4):157-60. PubMed ID: 6779387
[TBL] [Abstract][Full Text] [Related]
4. [Susceptibility of clinically important Bacteroides species against enoxacin-metronidazole and enoxacin-clindamycin combinations].
Heizmann WR; Werner H; Schmid R
Infection; 1989; 17 Suppl 1():S11-3. PubMed ID: 2807557
[TBL] [Abstract][Full Text] [Related]
5. [In vitro activity of an ofloxacin-metronidazole combination against anaerobic bacteria. Kinetics of the action of metronidazole against Bacteroides fragilis].
Dubreuil L; Devos J; Beerens H; Romond C
Pathol Biol (Paris); 1988 May; 36(5):488-92. PubMed ID: 3043345
[TBL] [Abstract][Full Text] [Related]
6. Synergic activity, for anaerobes, of trovafloxacin with clindamycin or metronidazole: chequerboard and time-kill methods.
Ednie LM; Credito KL; Khantipong M; Jacobs MR; Appelbaum PC
J Antimicrob Chemother; 2000 May; 45(5):633-8. PubMed ID: 10797085
[TBL] [Abstract][Full Text] [Related]
7. Study of the combination of ranitidine bismuth citrate and metronidazole against metronidazole-resistant Helicobacter pylori clinical isolates.
López-Brea M; Domingo D; Sánchez I; Prieto N; Alarcón T
J Antimicrob Chemother; 1998 Sep; 42(3):309-14. PubMed ID: 9786470
[TBL] [Abstract][Full Text] [Related]
8. BMY28142, cefbuperazone (T-1982), and Sch 34343. Antimicrobial activity against 94 anaerobes compared to seven other antimicrobial agents.
Jones RN; Barry AL; Packer RR
Diagn Microbiol Infect Dis; 1985 May; 3(3):263-8. PubMed ID: 3838925
[TBL] [Abstract][Full Text] [Related]
9. Susceptibility of 114 isolates of the Bacteroides fragilis group to imipenem and eight other antimicrobial agents.
Downes J; Andrew JH
Pathology; 1988 Jul; 20(3):260-3. PubMed ID: 3205597
[TBL] [Abstract][Full Text] [Related]
10. Synergism between penicillin, clindamycin, or metronidazole and gentamicin against species of the Bacteroides melaninogenicus and Bacteroides fragilis groups.
Brook I; Coolbaugh JC; Walker RI; Weiss E
Antimicrob Agents Chemother; 1984 Jan; 25(1):71-7. PubMed ID: 6142680
[TBL] [Abstract][Full Text] [Related]
11. Pharmacodynamics of pulse dosing versus standard dosing: in vitro metronidazole activity against Bacteroides fragilis and Bacteroides thetaiotaomicron.
Ibrahim KH; Gunderson BW; Hermsen ED; Hovde LB; Rotschafer JC
Antimicrob Agents Chemother; 2004 Nov; 48(11):4195-9. PubMed ID: 15504841
[TBL] [Abstract][Full Text] [Related]
12. Susceptibilities of 428 gram-positive and -negative anaerobic bacteria to Bay y3118 compared with their susceptibilities to ciprofloxacin, clindamycin, metronidazole, piperacillin, piperacillin-tazobactam, and cefoxitin.
Pankuch GA; Jacobs MR; Appelbaum PC
Antimicrob Agents Chemother; 1993 Aug; 37(8):1649-54. PubMed ID: 8215278
[TBL] [Abstract][Full Text] [Related]
13. Beta-lactamase production and susceptibilities to amoxicillin, amoxicillin-clavulanate, ticarcillin, ticarcillin-clavulanate, cefoxitin, imipenem, and metronidazole of 320 non-Bacteroides fragilis Bacteroides isolates and 129 fusobacteria from 28 U.S. centers.
Appelbaum PC; Spangler SK; Jacobs MR
Antimicrob Agents Chemother; 1990 Aug; 34(8):1546-50. PubMed ID: 2221864
[TBL] [Abstract][Full Text] [Related]
14. Inhibitory and bactericidal activity of selected beta-lactam agents alone and in combination with beta-lactamase inhibitors compared with that of cefoxitin and metronidazole against cefoxitin-susceptible and cefoxitin-resistant isolates of the Bacteroides fragilis group.
Stratton CW; Weeks LS; Aldridge KE
Diagn Microbiol Infect Dis; 1992; 15(4):321-30. PubMed ID: 1611847
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the bactericidal activity of clindamycin and metronidazole against cefoxitin-susceptible and cefoxitin-resistant isolates of the Bacteroides fragilis group.
Stratton CW; Weeks LS; Aldridge KE
Diagn Microbiol Infect Dis; 1991; 14(5):377-82. PubMed ID: 1797454
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of metronidazole and its principal metabolites and their activity against Gardnerella vaginalis.
Easmon CS; Ison CA; Kaye CM; Timewell RM; Dawson SG
Br J Vener Dis; 1982 Aug; 58(4):246-9. PubMed ID: 6980684
[TBL] [Abstract][Full Text] [Related]
17. Comparative susceptibility of the Bacteroides fragilis group species and other anaerobic bacteria to meropenem, imipenem, piperacillin, cefoxitin, ampicillin/sulbactam, clindamycin and metronidazole.
Goldstein EJ; Citron DM; Cherubin CE; Hillier SL
J Antimicrob Chemother; 1993 Mar; 31(3):363-72. PubMed ID: 8486570
[TBL] [Abstract][Full Text] [Related]
18. In-vitro and in-vivo activity of metronidazole against Gardnerella vaginalis, Bacteroides spp. and Mobiluncus spp. in bacterial vaginosis.
Jones BM; Geary I; Alawattegama AB; Kinghorn GR; Duerden BI
J Antimicrob Chemother; 1985 Aug; 16(2):189-97. PubMed ID: 3905748
[TBL] [Abstract][Full Text] [Related]
19. The activity of cefotaxime and desacetylcefotaxime alone and in combination against anaerobes and staphylococci.
Jones RN; Barry AL; Packer RR
Diagn Microbiol Infect Dis; 1984 Jun; 2(3 Suppl):37S-46S. PubMed ID: 6086217
[TBL] [Abstract][Full Text] [Related]
20. Comparative activity of trovafloxacin, alone and in combination with other agents, against gram-negative nonfermentative rods.
Visalli MA; Bajaksouzian S; Jacobs MR; Appelbaum PC
Antimicrob Agents Chemother; 1997 Jul; 41(7):1475-81. PubMed ID: 9210669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
